Nexalin Technology, Inc.
NXL- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001527352
No open-market purchases or sales by Nexalin Technology, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $281.6K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Nexalin Technology, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +3 vs. Q2 2024
- Shares held
- 428.7K
- +207.9K (+94.2%) vs. Q2 2024
- Total value
- $286.8K
- −$86.4K (−23.1%) vs. Q2 2024
- New holders
- 8
- 2 more added
- Sold out
- 5
- 3 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $281.6K |
| Q1 2026 | 23 | $373.6K |
| Q4 2025 | 19 | $682.6K |
| Q3 2025 | 20 | $638.3K |
| Q2 2025 | 21 | $1.31M |
| Q1 2025 | 17 | $774.5K |
| Q4 2024 | 19 | $1.04M |
| Q3 2024 | 15 | $286.8K |
| Q2 2024 | 13 | $466.9K |
| Q1 2024 | 5 | $88.9K |
| Q4 2023 | 3 | $18.3K |
| Q3 2023 | 5 | $36.0K |
| Q2 2023 | 4 | $11.0K |
| Q1 2023 | 7 | $45.5K |
| Q4 2022 | 7 | $32.5K |
| Q3 2022 | 2 | $21.0K |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Nexalin Technology, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 102,900 | $68.8K | 0.00% | +102,900 | New |
| Geode Capital Management, LLC | 78,697 | $52.6K | 0.00% | +34,635+78.6% | Added |
| Citadel Advisors LLC | 58,185 | $38.9K | 0.00% | +58,185 | New |
| Susquehanna International Group, LLP | 42,383 | $28.4K | 0.00% | +42,383 | New |
| Vanguard Group Inc | 31,780 | $21.3K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 23,447 | $16.0K | 0.00% | +23,447 | New |
| Two Sigma Securities, LLC | 23,045 | $15.4K | 0.00% | +23,045 | New |
| Atria Wealth Solutions, Inc. | 17,242 | $11.5K | 0.00% | −21,171−55.1% | Reduced |
| State Street Corp | 16,800 | $11.2K | 0.00% | 00.0% | Unchanged |
| Cetera Investment Advisers | 14,000 | $9.37K | 0.00% | +14,000 | New |
| Two Sigma Investments, LP | 10,658 | $7.13K | 0.00% | +10,658 | New |
| Tower Research Capital LLC (TRC) | 6,573 | $4.40K | 0.00% | −3,297−33.4% | Reduced |
| UBS Group AG | 2,466 | $1.65K | 0.00% | −1,570−38.9% | Reduced |
| Bank of America Corp | 73 | $49 | 0.00% | +27+58.7% | Added |
| Royal Bank of Canada | 500 | $0 | 0.00% | +500 | New |
| Morgan Stanley | 0 | $0 | 0.00% | −59,805−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −12,631−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Stone House Investment Management, LLC | 0 | $0 | 0.00% | −357−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| CVI Holdings, LLC | – | – | – | – | Not filed |